OBGYN 4 Flashcards
meds for acute abnormal uterine bleeding
high dose estrogens high dose OCPs high dose progestins tranexamic acid (antifibrinolytic)
workup of secondary amenorrhea (for at least 3 cycles or at least 6 months)
pregnancy test
if h/o uterine infection, do hysteroscopy
prolactin, TSH, FSH
2 vaginal cancers
- location
squamous cell: upper 1/3 vagina, posterior wall
clear cell adenocarcinoma: upper 1/3 vagina, anterior wall
h/o prior classic c-section or extensive myotomy, and now pregnant. management?
scheduled c section 36-37 weeks
severe features of preeclampsia
BP over 160/110 platelets less than 100,000 Cr greater than 1.1 or doubled incr AST or ALT pulm edema visual or cerebral sxs
management of preeclampsia
deliver baby if term
seizure proph: magnesium
HTN: labetalol, hydralazine, nifedipine (NHL)
CI in placenta previa
sex
digital cervical exam
vag delivery
indications for GBS prophylaxis (PCN) when GBS status unknown
delivery less than 37 weeks
membrane rupture at least 18 hours
GBS bacteriuria during pregnancy
h/o infant with GBS sepsis
indication for antenatal corticosteroids
PPROM before 32 weeks (for RDS, NEC, intraventricular hemorrhage, and death)
pregnant woman with Hep C. Next step?
make sure immunized to Hep A and Hep B
most effective post coital contraceptive
copper IUD
menopause labs
FSH incr
LH incr
FSH/LH less than 1
reason to do amniocentesis
determine fetal lung maturity
management of eclampsia-preeclampsia syndrome
mg sulfate for seizures
labetalol or hydrazine if BP greater than 160/110
augmentation or IOL
indications for c section
less than 32 weeks and unfavorable cervix
h/o many prior c sections
persistent non reassuring fetal heart tones
breech presentation
platelet transfusion in preeclampsia eclampsia is indicated when
less than 20,000
if c section, when less than 40-50,000
clinical presentation and US findings of epithelial ovarian CA
SOB constipation/vomiting abd distention pelvic pain early satiety
solid mass
thick septations
ascites
management if BPP is 6/10
repeat in 24 hours
characteristics of fetal hydration syndrome (from phenytoin)
midface hypoplasia microcephaly cleft lip and palate digital hypoplasia hirsutism developmental delay
biggest risk factor for cerebral palsy
prematurity
management of endometrial hyperplasia without atypia
progestin therapy
management of endometrial hyperplasia with atypia
if want future pregnancy: progestin therapy
no plans for pregnancy or failed meds: hysterectomy
hormone that maintains corpus luteum
hCG
hormone that inhibits uterine contractions
progesterone
hormone that induces prolactin production in pregnancy
estrogen
indications for magnesium sulfate
prevent eclamptic seizures
imminent preterm delivery to decrease risk of cerebral palsy
tx of magnesium toxicity
calcium gluconate
